Home-Based Long-Term Physical Endurance and Inspiratory Muscle Training for Children and Adults With Fontan Circulation-Initial Results From a Prospective Study.
Fontan circulation
cardiopulmonary exercise testing (CPET)
endurance training
inspiratory muscle training (IMT)
quality of life
Journal
Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388
Informations de publication
Date de publication:
2021
2021
Historique:
received:
28
09
2021
accepted:
28
12
2021
entrez:
24
2
2022
pubmed:
25
2
2022
medline:
25
2
2022
Statut:
epublish
Résumé
Patients with congenital heart disease (CHD)-including those after Fontan operation-are encouraged to be physically active. To prospectively determine the effects of an individually adapted, home-based cycle ergometer endurance training in combination with inspiratory muscle training (IMT) in pediatric and adult Fontan patients. We, herein, report the results of the initial 10-months follow-up (phase 1). 18 patients (median age 16.5 years; range 10-43 years) completed baseline check-ups, and 4 and 10 months follow-up visits, which each included cardiopulmonary exercise testing (CPET), bodyplethysmography (including measurement of respiratory muscle strength), and a quality of life questionnaire (PedsQL™). The training program consisted of a home-based cycle ergometer endurance training on a "Magbike® AM-5i/3i" (DKN Technology®, Clermont-Ferrand, France) and IMT with a handheld "POWERbreathe® Medic plus" device. Patients performed 90 min of endurance training per week in addition to IMT (30 breaths per day, 6-7 times per week). After the first 4 months, patients underwent additional interval training. After 10 months of training, we observed significant increases in maximum relative workload (W/kg, In Fontan patients, an individually adapted home-based training is safe and associated with improvements in some CPET variables. However, these improvements did not translate into an improved QoL after 10 months. With an unclear, but most likely negative, impact of the COVID-19 pandemic, improvements in QoL may become evident during further follow-up (phase 2 of the study).
Sections du résumé
BACKGROUND
BACKGROUND
Patients with congenital heart disease (CHD)-including those after Fontan operation-are encouraged to be physically active.
AIM
OBJECTIVE
To prospectively determine the effects of an individually adapted, home-based cycle ergometer endurance training in combination with inspiratory muscle training (IMT) in pediatric and adult Fontan patients. We, herein, report the results of the initial 10-months follow-up (phase 1).
METHODS
METHODS
18 patients (median age 16.5 years; range 10-43 years) completed baseline check-ups, and 4 and 10 months follow-up visits, which each included cardiopulmonary exercise testing (CPET), bodyplethysmography (including measurement of respiratory muscle strength), and a quality of life questionnaire (PedsQL™). The training program consisted of a home-based cycle ergometer endurance training on a "Magbike® AM-5i/3i" (DKN Technology®, Clermont-Ferrand, France) and IMT with a handheld "POWERbreathe® Medic plus" device. Patients performed 90 min of endurance training per week in addition to IMT (30 breaths per day, 6-7 times per week). After the first 4 months, patients underwent additional interval training.
RESULTS
RESULTS
After 10 months of training, we observed significant increases in maximum relative workload (W/kg,
DISCUSSION
CONCLUSIONS
In Fontan patients, an individually adapted home-based training is safe and associated with improvements in some CPET variables. However, these improvements did not translate into an improved QoL after 10 months. With an unclear, but most likely negative, impact of the COVID-19 pandemic, improvements in QoL may become evident during further follow-up (phase 2 of the study).
Identifiants
pubmed: 35198605
doi: 10.3389/fcvm.2021.784648
pmc: PMC8858796
doi:
Types de publication
Journal Article
Langues
eng
Pagination
784648Informations de copyright
Copyright © 2022 Dirks, Kramer, Schleiger, Speck, Wolfarth, Thouet, Berger, Sallmon and Ovroutski.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Circulation. 2006 Feb 28;113(8):1123-9
pubmed: 16490823
Eur Respir Rev. 2016 Dec;25(142):438-450
pubmed: 27903666
Pediatrics. 2004 Aug;114(2 Suppl 4th Report):555-76
pubmed: 15286277
Ann Thorac Surg. 2008 Mar;85(3):818-21
pubmed: 18291148
Congenit Heart Dis. 2016 Mar-Apr;11(2):175-82
pubmed: 26879633
J Am Coll Cardiol. 2006 May 16;47(10):2065-73
pubmed: 16697327
Can J Cardiol. 2006 May 1;22(6):489-95
pubmed: 16685313
Can J Cardiol. 2009 Sep;25(9):e294-300
pubmed: 19746247
Circulation. 1990 Jun;81(6):2016-7
pubmed: 2344688
Acta Paediatr. 2020 Apr;109(4):651-658
pubmed: 31737940
J Am Heart Assoc. 2016 Jun 16;5(6):
pubmed: 27312802
Am Heart J. 2015 Sep;170(3):606-14
pubmed: 26385046
Eur Respir J. 2021 Mar 11;57(3):
pubmed: 33707167
Congenit Heart Dis. 2018 Mar;13(2):181-193
pubmed: 29372588
J Am Heart Assoc. 2017 Aug 21;6(8):
pubmed: 28862962
Eur Heart J. 2013 Dec;34(47):3669-74
pubmed: 24204010
Congenit Heart Dis. 2017 Dec;12(6):699-710
pubmed: 28795517
Eur J Cardiothorac Surg. 2005 Jan;27(1):53-7
pubmed: 15621471
Am J Cardiol. 2005 Jan 1;95(1):150-2
pubmed: 15619417
Int J Cardiol. 2020 Apr 15;305:50-55
pubmed: 31992463
Int J Cardiol. 2010 Jan 21;138(2):196-205
pubmed: 19217676
Congenit Heart Dis. 2019 Mar;14(2):147-155
pubmed: 30378270
J Heart Lung Transplant. 2019 Sep;38(9):879-901
pubmed: 31495407
Circulation. 2014 Sep 9;130(11 Suppl 1):S32-8
pubmed: 25200053
Coll Antropol. 2011 Dec;35(4):1285-90
pubmed: 22397273
Eur Heart J. 2012 Jun;33(11):1386-96
pubmed: 22199119
Eur Heart J. 2012 Jun;33(11):1378-85
pubmed: 22036871
Eur J Cardiothorac Surg. 2005 Apr;27(4):561-5
pubmed: 15784351
Thorax. 1971 May;26(3):240-8
pubmed: 5089489
Int J Cardiol. 2021 Dec 1;344:87-94
pubmed: 34563595
Cardiol Young. 2018 Sep;28(9):1115-1122
pubmed: 29972111
Int J Cardiol. 2013 Sep 30;168(2):780-8
pubmed: 23154055
Pediatrics. 2008 May;121(5):e1060-7
pubmed: 18450848
Cardiol Young. 2021 Jan;31(1):77-83
pubmed: 33081857
Respiration. 2018;95(4):235-243
pubmed: 29342462
Pacing Clin Electrophysiol. 1997 Feb;20(2 Pt 2):502-11
pubmed: 9058852
Cardiol Young. 2018 Mar;28(3):438-446
pubmed: 29237518
J Am Heart Assoc. 2020 Nov 17;9(22):e017704
pubmed: 33153356
J Am Coll Cardiol. 2008 Jul 8;52(2):99-107
pubmed: 18598887
Heart. 2018 Sep;104(18):1508-1514
pubmed: 29535229
Eur Respir J. 2012 Dec;40(6):1324-43
pubmed: 22743675
Trials. 2017 Jan 23;18(1):38
pubmed: 28115007
Int J Cardiol. 2013 Dec 5;170(1):24-9
pubmed: 24207068
J Am Coll Cardiol. 2011 Jun 14;57(24):2437-43
pubmed: 21658565
Congenit Heart Dis. 2017 Jul;12(4):399-402
pubmed: 28618202
Heart. 2020 Mar;106(5):333-341
pubmed: 31806699
Eur Heart J. 2009 Dec;30(23):2915-20
pubmed: 19692392
Cardiol Young. 2018 Nov;28(11):1299-1305
pubmed: 30149816
Circulation. 2019 Jul 1;:CIR0000000000000696
pubmed: 31256636
Eur J Prev Cardiol. 2021 Sep 20;28(11):1269-1278
pubmed: 34551076
J Am Heart Assoc. 2019 May 7;8(9):e012008
pubmed: 31041880
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Jul;57(7):840-8
pubmed: 24950833